Leukemia, Mast-Cell - 13 Studies Found

Completed : Phase II Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD
: Leukemia, Mast-Cell
: 2005-09-14
:
  • Procedure: nonmyeloablative allogeneic hematopoietic cell transplant

Active, not recruiting : Phase II Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia
:
  • Systemic Mastocytosis, Aggressive (ASM)
  • Leukemia, Mast Cell : 2005-10-03
    : Drug: Midostaurin Midostaurin is a broad-spectrum protein kinase inhibitor, acting on conventional PKC i
Recruiting : Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia
:
  • Aggressive Systemic Mastocytosis
  • Mast Cell Leukemia
  • : 2013-03-05
    : Drug: brentuximab vedotin Brentuximab vedotin is an antibody with a covalently attached toxin. The antib
Active, not recruiting : Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
: Leukemia
: 2008-10-28
: Drug: Midostaurin (PKC412) Midostaurin was provided as 25 mg soft gelatin capsules for oral administrati
Recruiting : Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis
:
  • Aggressive Systemic Mastocytosis
  • Mast Cell Leukemia
  • : 2015-03-24
    :
    • Drug: Ibrutinib Given PO
Recruiting : Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (advSM) and Relapsed or Refractory Myeloid Malignancies
:
  • Aggressive Systemic Mastocytosis
  • Systemic Mastocytosis-associated Hematologic Non-mast Cell
    : 2015-09-15
    : Drug: BLU-285
Completed : Patient-Reported Outcome Questionnaire for Systemic Mastocytosis
:
  • Aggressive Systemic Mastocytosis (ASM)
  • SM w Assoc Clonal Hema Non-mast Cell Lineage Disease
    : 2015-02-26
    : Other: Interview Single interview lasting approximately one hour
Completed : Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies
:
  • Acute Undifferentiated Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remission
  • : 2011-01-07
    :
    • Drug: deferasirox Given orally
Recruiting : Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
:
  • Acute Undifferentiated Leukemia
  • Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
    • : 2009-05-09
    : Other: cytology specimen collection procedure Correlative studies
Terminated : Sunitinib in Treating Patients With Idiopathic Myelofibrosis
:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Acute Undifferentiated Leukemia
  • : 2006-10-12
    : Drug: sunitinib malate Given PO
Next >>>